LEADS

Check us out at leads-study.org @DrMariaALZ

Visit us at the LEADS booth at #aaic25! We are part of the NIA Pavilion, Booth 609F. Hear about our data sharing efforts and how you can take part in advancing research on EOAD. Please share widely.

Here's what you can see from the Apostolova Lab tomorrow, Monday July 17th! #AAIC23 #ENDALZ @ApostolovaLiana

@BrianGordon81 @LEADS_study @NeuroimagingPIA Here are the lovely faces of the wonderful faculty and trainees who are presenting the wealth of #LEADS data at #AAIC23 @_paigely @relajoie @TouroutoglouA @eloyan_ani @Ralyoyo @schonhaut @LEADS_study @RabLab_UCSF @DickersonLabMGH @DrMariaALZ

Check out these poster presentations from the #LEADS study at the #AAIC23

Do not miss these oral presentations from the #LEADS study. #AAIC23

LEADS poster presentations at the AIC #AAIC23

Episode 3 of this up and coming Medscape series is focused on EOAD and LEADS. Heartbreaking! medscape.com/mtv/alzheimers…

Topics include but not limited to: 🧠 Early onset #AD: LEAD study 🧠 New hypothesis of AD pathogenesis 🧠 AD and gut microbiome 🧠 Artificial intelligence (#AI) in AD 🧠 Imaging biomarkers/ATN staging 🧠 CSF biomarkers 🧠 #DBS, #TMS and #tDCS in AD 🧠 Drug development

A great pleasure to work with many field leaders and experts on this meaningful work- @MedscapeNeuro Decision Point: #Alzheimers & related #dementia section. 🫴 Pls check our expert video commentaries on guidelines & practice recommendation. More to come! decisionpoint.medscape.com/neurology

Here is a video of one of my favorite LEADS couples - Mary and Peggy! Mary is one of my bravest patients. She developed problems with memory in her late 50s. Such a heartwarming interview. Click on the link: youtube.com/watch?v=RtvXb3…

Proudly presenting the full-length AAN TV feature of LEADS! #AANAM2023 @AANmember @ApostolovaLiana @DrMariaALZ @AlzIndiana @NeurosciStark @IUMedSchool @iadrc_iu tinyurl.com/4wshajhj

LEADS was featured on AAN TV and recognized as one of the most important AD observational studies. SUCH an honor! @NeurosciStark @iadrc_iu @IUMedSchool #ENDALZ @DrMariaALZ

We compared 10 different p-tau assays for detection of amyloid pathology (important for anti-amyloid immunotherapies) and progression to AD dementia (important for prognosis). The results are clear; p-tau217 is the best p-tau biomarker in symptomatic AD, independent of method.

This feature was filmed by AAN TV and will be playing at the AAN in Boston next week. We hope to increase referrals from our fellow neurologists. EOAD is rare. We need your help!

Why is LEADS an important study? Please watch: youtube.com/watch?v=tvqeSQ…

Great presentation on @LEADS_study at @adpdnet by @ApostolovaLiana of @iadrc_iu @IUMedSchool @NeurosciStark! #ADPD2023

Call for papers for the 2023 DADM special issues: - IADLs and Neuropsychiatric Symptoms in ADRD - Sensory Changes in ADRD - Bayesian Methods that Address the Questions We Actually Ask The deadline to submit your work is August 15, 2023 @alzdemjournals @WileyNeuro .

Honored to have @ApostolovaLiana as my mentor! She is an exceptional leader and a true source of inspiration and support for everyone in our lab. I am so grateful to be her trainee and to have been a part of this nomination process. Congratulations again!!

Congratulations to @nemes_sara (Apostolova Lab), @NeuroJenya (Saykin and Sporns Labs) and Rachael Deardorff (Saykin Lab) for becoming the recipients of the 2023 John West Scholar Awards from the @iadrc_iu!

Submitted! Crossing my fingers this is how everyone will see me (and my fellow lab mates) in mid-July this year. Go @LEADS_study!!! #AAIC2023